Home > Boards > US Listed > Medical - Drugs > Altimmune, Inc (ALT)

Bought at 4.40, and sold in the 3s

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
0whammies Member Profile
 
Followed By 29
Posts 4,201
Boards Moderated 0
Alias Born 03/05/18
160x600 placeholder
Altimmune to Announce First Quarter 2021 Financial Results on May 17, 2021 GlobeNewswire Inc. - 5/11/2021 7:00:00 AM
Altimmune reports encouraging AdCOVID data in SARS-CoV-2 challenged mice Seeking Alpha - 5/10/2021 9:41:29 AM
Altimmune Announces New Preclinical Data for AdCOVID™ Demonstrating Sterilizing Immunity After a Single Intranasal Dose GlobeNewswire Inc. - 5/10/2021 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/4/2021 7:01:06 PM
Altimmune to Present at Upcoming Scientific Conferences GlobeNewswire Inc. - 4/29/2021 7:00:00 AM
Altimmune highlights safety of anthrax vaccine candidate with early-stage results Seeking Alpha - 4/1/2021 3:16:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/1/2021 7:31:32 AM
Altimmune Reports Data from its Phase 1b Clinical Trial of NasoShield™ GlobeNewswire Inc. - 4/1/2021 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/31/2021 7:01:25 PM
AstraZeneca’s foray into COVID-19 nasal spray sparks interest in Altimmune Seeking Alpha - 3/26/2021 1:45:41 PM
Altimmune Partners with Summit Biosciences to Produce a Multidose Nasal Spray Presentation of its AdCOVID™ Vaccine Candidat... GlobeNewswire Inc. - 3/22/2021 7:00:00 AM
Altimmune shares rise 11% as COVID-19 vaccine prevents infection, reduces virus replication Seeking Alpha - 3/15/2021 8:33:26 AM
AdCOVID™, Altimmune’s Single Dose, Intranasal COVID-19 Vaccine Candidate, Prevents SARS-CoV-2-induced Disease and Blocks ... GlobeNewswire Inc. - 3/15/2021 7:00:00 AM
Altimmune Extends Lonza Partnership To Support Production Of AdCOVID TipRanks - 3/14/2021 5:18:08 AM
Altimmune Expands Manufacturing Agreement for Covid-19 Vaccine Candidate Dow Jones News - 3/12/2021 6:44:00 AM
Altimmune expands AdCOVID manufacturing pact with Lonza Seeking Alpha - 3/12/2021 3:18:43 AM
Altimmune Expands AdCOVID™ Manufacturing Collaboration with Lonza GlobeNewswire Inc. - 3/12/2021 1:00:00 AM
Altimmune to Present at Upcoming Conferences GlobeNewswire Inc. - 3/8/2021 4:01:00 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 3/1/2021 4:09:53 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/1/2021 4:04:31 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/25/2021 4:06:55 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 2/25/2021 8:19:57 AM
Altimmune EPS beats by $0.68, beats on revenue Seeking Alpha - 2/25/2021 7:19:23 AM
Annual Report (10-k) Edgar (US Regulatory) - 2/25/2021 7:12:23 AM
Altimmune starts enrollment in phase 1 COVID-19 trial of Adcovid Seeking Alpha - 2/25/2021 7:10:04 AM
0whammies   Monday, 03/01/21 09:14:19 PM
Re: catchmeifyoucan post# 1480
Post # of 1487 
Bought at 4.40, and sold in the 3s last year. The Moon is next....what happens.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences